SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-022069
Filing Date
2024-07-03
Accepted
2024-07-03 06:02:06
Documents
7
Effectiveness Date
2024-07-03
Reference 429
333-267984

Document Format Files

Seq Description Document Type Size
1 FORM S-8 vxrt20240702_s8.htm S-8 66442
2 EXHIBIT 5.1 ex_695095.htm EX-5.1 9488
3 EXHIBIT 23.1 ex_695226.htm EX-23.1 2555
4 EXHIBIT FILING FEES ex_695096.htm EX-FILING FEES 12826
5 vaxart01.jpg GRAPHIC 10159
6 withumfooter.jpg GRAPHIC 17348
7 withumlogo.jpg GRAPHIC 11331
  Complete submission text file 0001437749-24-022069.txt   146621
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280669 | Film No.: 241098159
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)